On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

CLN3

CLN3 lysosomal/endosomal transmembrane protein, battenin

The CLN3 gene encodes a transmembrane protein, battenin, primarily found in lysosomes, which are critical for cellular waste digestion and recycling. The CLN3 gene provides instructions for a protein named battenin, which is located in cellular compartments called lysosomes.

Chromosome 16p12.1 Autosomal recessive HGNC:2074 Tier C
CLN3 16p12.1 p arm q arm 16

CLN3 is located on the short (p) arm of chromosome 16, at band 16p12.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 16 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The CLN3 gene, also known as battenin, produces a protein that is widely distributed across bodily tissues. While its precise function is still being investigated, the CLN3 protein is predominantly located within lysosomes. These membrane-bound organelles serve as sites where cells degrade unwanted materials and salvage useful components.

Dysfunction of the CLN3 protein, often due to pathogenic variants in the gene, is primarily linked to Neuronal ceroid lipofuscinosis 3 (CLN3 disease), a severe neurological disorder that typically manifests in childhood.

What the gene does

Instructions encoded by the CLN3 gene lead to synthesis of a protein embedded within lysosomal membranes. Research suggests this protein helps coordinate signals passing between lysosomes and other cellular structures. Its exact molecular duties remain under investigation, though evidence points to a role in how lysosomes break down and repurpose various cellular molecules.

The protein appears in multiple compartments inside cells, with scientists focusing most attention on its lysosomal activities. Whether the protein's primary job involves one specific task or encompasses several related processes is not yet certain. Some observed cellular effects may stem indirectly from the protein's core function rather than representing direct actions.

Video: Genetics 101

Chromosome location

The CLN3 gene is situated on the short arm of chromosome 16 at position 12.1, denoted as 16p12.1. This genomic location specifies where the gene can be found within the human genome.

Protein structure

The CLN3 protein consists of 438 amino acids. It contains several notable structural features, including two disordered regions: one at the N-terminus spanning amino acids 1-25 and another located between amino acids 237-268. The protein also features multiple lysosomal targeting motifs, which are crucial for directing the protein to the lysosomes. Specific lysosomal targeting motifs are found at amino acids 242-244, 253-254 (which is also required for interaction with AP1G1, AP2A2, and AP3D1), and 409-419.

Domain map · 438 amino acids
Lysosomal targeting motif (242-244)Lysosomal targeting motif. Required for AP1G1, AP2A2 and AP3D1 interaction (253-254)Lysosomal targeting motif (409-419)Lysosomal targeting mo242-244Lysosomal targeting mo253-254Lysosomal targeting mo409-4191~219438
Motif - short conserved sequence
🧬 Explore 3D structure on AlphaFold
UniProt:Q13286Length:438 aaStructure:AlphaFold

Key variants

Variants in the CLN3 gene can lead to changes in the battenin protein, potentially impairing its normal function within lysosomes. These genetic alterations can include deletions, insertions, or substitutions of DNA building blocks. The impact of a specific variant depends on its location and the resulting alteration to the protein structure or production.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for CLN3.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1115_1118dup
Duplication
p.Val374fs Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis 3
c.126G>A
single nucleotide variant
p.Trp42Ter Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis
c.379dup
Duplication
p.Arg127fs Pathogenic/Likely pathogenic ★★☆☆ CLN3-related disorders
c.3G>A
single nucleotide variant
p.Met1Ile Pathogenic/Likely pathogenic ★★☆☆ Juvenile neuronal ceroid lipofuscinosis
c.461-2A>G
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis
c.551G>A
single nucleotide variant
p.Trp184Ter Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis
c.552G>A
single nucleotide variant
p.Trp184Ter Pathogenic/Likely pathogenic ★★☆☆ Juvenile neuronal ceroid lipofuscinosis
c.729del
Deletion
p.Glu244fs Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis
c.83del
Deletion
p.Leu28fs Pathogenic/Likely pathogenic ★★☆☆ CLN3-related disorder
c.849G>A
single nucleotide variant
p.Trp283Ter Pathogenic/Likely pathogenic ★★☆☆ Neuronal ceroid lipofuscinosis

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants within the CLN3 gene are primarily associated with Neuronal ceroid lipofuscinosis 3 (Batten, CLN3). This inherited disorder typically begins in childhood and progressively affects the nervous system, leading to symptoms such as vision loss, intellectual disability, and movement difficulties. More than 65 pathogenic variants in the CLN3 gene have been identified as causing CLN3 disease. In some instances, CLN3 gene variants can also cause CLN3-associated isolated retinal degeneration, which results in vision impairment due to retinal breakdown without the full spectrum of CLN3 disease symptoms.

Inheritance pattern

Conditions caused by pathogenic CLN3 variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous CLN3 carrier status across ancestry groups?

UK clinical status

The CLN3 gene is included in several expert-curated panels within the NHS Genomic Medicine Service's PanelApp. It is marked 'green' for conditions such as Neuronal ceroid lipofuscinosis (R231), Lysosomal storage disorder (R276), and Intellectual disability. This indicates that there is strong evidence for the gene's association with these conditions in a clinical diagnostic setting.

Frequently asked questions

What is the primary function of the CLN3 gene?

The CLN3 gene encodes a protein called battenin that resides in lysosomes. Evidence suggests this protein helps lysosomes digest and recycle different types of molecules, and facilitates communication between lysosomes and other parts of the cell. However, the protein's precise primary role remains under active investigation.

What condition is associated with variants in the CLN3 gene?

Pathogenic variants in the CLN3 gene are primarily associated with Neuronal ceroid lipofuscinosis 3 (Batten disease), a progressive neurological disorder. In some cases, variants may also cause CLN3-associated isolated retinal degeneration, leading to vision impairment.

How does the CLN3 protein contribute to cellular health?

The CLN3 protein is positioned within lysosomal membranes, where it is thought to support the lysosome's ability to digest and recycle cellular molecules. By facilitating communication between lysosomes and the rest of the cell, the protein may help coordinate essential waste-management processes, though scientists are still clarifying which functions represent its primary role.

References

  1. Mirza M, Vainshtein A, DiRonza A. The CLN3 gene and protein: What we know. Molecular genetics & genomic medicine. 2019. PMID: 31568712
  2. Ku CA, Hull S, Arno G. Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration. JAMA ophthalmology. 2017. PMID: 28542676
  3. Oetjen S, Kuhl D, Hermey G. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis. Journal of neurochemistry. 2016. PMID: 27453211
  4. Cárcel-Trullols J, Kovács AD, Pearce DA. Cell biology of the NCL proteins: What they do and don't do. Biochimica et biophysica acta. 2015. PMID: 25962910
  5. Uusi-Rauva K, Kyttälä A, van der Kant R. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments. Cellular and molecular life sciences : CMLS. 2012. PMID: 22261744
  6. Cotman SL, Staropoli JF. The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking. Clinical lipidology. 2012. PMID: 22545070
  7. Kitzmüller C, Haines RL, Codlin S. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Human molecular genetics. 2008. PMID: 17947292
  8. Rakheja D, Narayan SB, Bennett MJ. The function of CLN3P, the Batten disease protein. Molecular genetics and metabolism. 2008. PMID: 18688960
  9. Phillips SN, Benedict JW, Weimer JM. CLN3, the protein associated with batten disease: structure, function and localization. Journal of neuroscience research. 2005. PMID: 15657902
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .